Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2025
February 11 2025 - 10:45AM
Business Wire
Pursuant to article L-223-8 II of the French
“code de Commerce” and 223-16 of the AMF’s General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
18,631,386
Number of real voting rights*
(excluding treasury shares**)
18,567,201
Theoretical number of voting
rights* (including treasury shares**)
18,608,186
(*) Class E preference shares are non-voting
(**) pursuant to article 223-11 of the AMF’s General
Regulations
About Median Technologies: Pioneering innovative software as a
medical device and imaging services, Median Technologies harnesses
cutting-edge AI to enhance the accuracy of early cancer diagnoses
and treatments. Median's offerings include iCRO, which provides
medical image analysis and management in oncology trials, and
eyonis™, an AI/ML tech-based suite of software as a medical device
(SaMD). Median empowers biopharmaceutical entities and clinicians
to advance patient care and expedite the development of novel
therapies. The French-based company, with a presence in the U.S.
and China, trades on the Euronext Growth market (ISIN:
FR0011049824, ticker: ALMDT). Median is also eligible for the
French SME equity savings plan scheme (PEA-PME). For more
information, visit www.mediantechnologies.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250211459162/en/
Median Technologies Emmanuelle Leygues VP, Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49
24 ghislaine.gasparetto@seitosei-actifin.com
Median Technologies (EU:ALMDT)
Historical Stock Chart
From Jan 2025 to Feb 2025
Median Technologies (EU:ALMDT)
Historical Stock Chart
From Feb 2024 to Feb 2025
